Stuart joined OBN as CEO in May 2022. He has over 30 years’ experience in the life science arena. Originally graduating in biological sciences, he started his career in pharmaceutical sales before moving into international marketing in consumer healthcare and prescription medicines.

His career in life sciences spans global pharma companies, a university spin-out, mid cap biopharma, privately-owned SMEs, strategic consulting, advising PE & VC investors and leadership of a not-for-profit organisation. Latterly, he spent 13 years as Managing Director for Merz Pharma UK, building the business up to be one of the premier performing affiliates in the Group.

Stuart has also supported the UK industry through extra-curricular roles including the ABPI Small Companies Forum, judging for several industry awards, a Steering Group member for the Ethical Medicines Industry Group and a decade serving on the Prescription Medicines Code of Practice Authority Appeal Board. He is passionate about the life sciences industry and enjoys DIY, travel and wine.